The prognostic significance of BAP1, NF2, and CDKN2A in malignant peritoneal mesothelioma. - Test2 - elhamkhani - TriplyDB

The prognostic significance of BAP1, NF2, and CDKN2A in malignant peritoneal mesothelioma.

The prognostic significance of BAP1, NF2, and CDKN2A in malignant peritoneal mesothelioma.

http://www.wikidata.org/entity/Q38950690

about

Loss of BAP1 Expression Is Very Rare in Pancreatic Ductal Adenocarcinoma.Intraoral Pseudo-Onion Bulb Intraneural Proliferations in a Patient with Hemimandibular Hyperplasia: A Case Report and Review of the Literature.Genomic profiling of malignant peritoneal mesothelioma reveals recurrent alterations in epigenetic regulatory genes BAP1, SETD2, and DDX3X.Inhibition of the spindle assembly checkpoint kinase Mps-1 as a novel therapeutic strategy in malignant mesothelioma.BAP1 mutations in high-grade meningioma: implications for patient care.Novel insights into mesothelioma biology and implications for therapy.Diagnostic utility of BAP1 and EZH2 expression in malignant mesothelioma.Peritoneal Mesothelioma with Residential Asbestos Exposure. Report of a Case with Long Survival (Seventeen Years) Analyzed by Cgh-Array.Malignant Mesothelioma, BAP1 Immunohistochemistry, and VEGFA: Does BAP1 Have Potential for Early Diagnosis and Assessment of Prognosis?A case of peritoneal malignant mesothelioma following radiation therapy for cervical cancer.Identification of ALK Rearrangements in Malignant Peritoneal Mesothelioma.Targeting the Hippo Pathway Is a New Potential Therapeutic Modality for Malignant Mesothelioma.Loss of Chromatin Remodeling Proteins and/or CDKN2A Associates With Metastasis of Pancreatic Neuroendocrine Tumors and Reduced Patient Survival Times.Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion in Adolescent and Young Adults with Peritoneal Metastases.RETRACTED: Analysis of YAP1 and TAZ expression by immunohistochemical staining in malignant mesothelioma and reactive mesothelial cells.Novel insights and recent discoveries on the genetics and pathogenesis of malignant mesothelioma.MiR-21 over-expression and Programmed Cell Death 4 down-regulation features malignant pleural mesothelioma.NF2/Merlin Inactivation and Potential Therapeutic Targets in Mesothelioma.Malignant peritoneal mesothelioma: clinical aspects, and therapeutic perspectives

P2860

Q35959422-4885BE6D-60CF-47DF-AC31-B955AE60540B Q37370134-4DD840B4-3E06-49F9-8AD3-782D80A10155 Q37619913-26A66E6E-25BA-486D-8915-A46267D8BBF2 Q38429562-361A50F9-6DD2-454D-A311-6C912DD7A55F Q39290955-BE3FA651-2685-48CA-BA30-21DA50EF1E26 Q39455555-B309D425-E13F-455D-BDCA-44A916717E8D Q40470064-C4112C6C-2F84-4CBD-AE01-919266B378AA Q42352210-CEFEF533-BF19-446A-AA1C-0233AF9D184F Q42728294-56D218C3-FB2E-4AE8-9B73-A13FBD389D27 Q49458449-DC52833D-2818-4AF8-96C6-B316239B109A Q50091853-7797BB1B-438E-47DE-9377-7121F0198CBE Q52642770-C97A9739-AC43-4FE2-9996-C83DDBE78EC0 Q52688905-E78A4E98-52D0-4983-B62B-CD81C2A7FC63 Q52939514-D55DD614-6D42-4714-B382-7B886439297E Q54112034-4EE2F7A1-9219-4A43-A9CD-B5A40C6AC019 Q55078347-3928DDDC-0D17-4683-8189-2C323F308278 Q55183040-122D013E-5A7D-4F94-8367-40948B5FF41B Q55355075-FEE6BC19-1FFD-4866-A983-88DF2B13E8C4 Q58541846-788B8403-D803-4F40-AE27-A167C4E75B75

P2860

The prognostic significance of BAP1, NF2, and CDKN2A in malignant peritoneal mesothelioma.

http://www.wikidata.org/entity/Q38950690

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

The prognostic significance of ...... gnant peritoneal mesothelioma.

@en

type

label

The prognostic significance of ...... gnant peritoneal mesothelioma.

@en

prefLabel

The prognostic significance of ...... gnant peritoneal mesothelioma.

@en

P1433

Q38950690-2ADB88D6-2B53-4237-B73D-806F89E791AB

P1476

Q38950690-97E6261C-A6E2-483B-925D-256EA2AAC76E

P2093

Q38950690-150A6415-9E39-4513-A685-DC0C007054DF

Q38950690-1C995E8B-8701-4FF2-8627-7588E67DE8BD

Q38950690-4BAB482C-2F54-48D8-9AD6-3142D2257271

Q38950690-4EA00969-3062-4042-B88E-FA3A86C1EF5C

Q38950690-6C2236DD-8CBF-4700-AD4A-0C2745C710EC

Q38950690-876D1E28-A68B-4E96-A239-A6A8C394F2E0

Q38950690-B59E1A2C-1D83-45AF-9644-35D863E87F88

Q38950690-D8E55493-DB4F-4129-A389-22413120F210

Q38950690-D9E17407-6589-4C9B-95B1-E8D6C2FCB92B

Q38950690-E2B2F4BD-A4CD-4CE2-92FD-74DFBE9C384B

P2860

Q38950690-0B2C29ED-56A9-4D6F-B341-F4AA8CFF3AF0

Q38950690-0DC0FAF4-E0D4-4779-8CFC-BBE2AF825417

Q38950690-0E566552-0AA4-4513-8833-073DA37E19C3

Q38950690-183F0851-C56E-43E6-AE44-D3193B34FF5E

Q38950690-39094B6C-4722-4F67-A7DD-F30B952789F7

Q38950690-3A76D7E7-2039-4A2C-A49F-0818ED070720

Q38950690-3A8C5DEB-8EBB-46EC-8C4D-CE2F720DB7B2

Q38950690-48850247-881A-4046-AD62-E8493C33AA9C

Q38950690-56594E87-CAA5-46F1-8BC9-DB282BFB53CF

Q38950690-56D0B78A-10A5-407B-AD87-663006C040BC

P2888

Q38950690-D086E464-D4A5-4267-AC23-BAD470E2A668

P304

Q38950690-46179674-ADFE-4624-9C25-2E6055156544

P31

Q38950690-F9F0F4AE-FBC4-4510-9D9D-F4CB2E68320A

P356

Q38950690-47964751-F9DF-4B0E-9079-CB39405464FB

P433

Q38950690-EEA9BF66-4838-47B1-84B6-4085E6916215

P478

Q38950690-140EEA1D-5369-4856-9E8E-C4EC0189124A

P577

Q38950690-F22BC95A-832E-487A-94FF-D0DFC69C67EF

P6179

Q38950690-43F7D90F-6C7D-4CB3-B158-92F75258DF6C

P698

Q38950690-D28D6B71-F6B0-4AD9-AADE-0E96A3EF83DF

P356

MODPATHOL.2015.121

P1433

Modern Pathology

P1476

The prognostic significance of ...... gnant peritoneal mesothelioma.

@en

P2093

Aatur D Singhi

http://www.w3.org/2001/XMLSchema#string

Alyssa Luvison

http://www.w3.org/2001/XMLSchema#string

Alyssa M Krasinskas

http://www.w3.org/2001/XMLSchema#string

David L Bartlett

http://www.w3.org/2001/XMLSchema#string

Haroon A Choudry

http://www.w3.org/2001/XMLSchema#string

Herbert J Zeh

http://www.w3.org/2001/XMLSchema#string

James F Pingpank

http://www.w3.org/2001/XMLSchema#string

Kimberly Fuhrer

http://www.w3.org/2001/XMLSchema#string

Nathan Bahary

http://www.w3.org/2001/XMLSchema#string

Raja R Seethala

http://www.w3.org/2001/XMLSchema#string

P2860

High incidence of somatic BAP1 alterations in sporadic malignant mesothelioma

A new standard of care for the management of peritoneal surface malignancy

Mesothelioma trends in the United States: an update based on Surveillance, Epidemiology, and End Results Program data for 1973 through 2003.

Prognostic significance of p16/cdkn2a loss in pleural malignant mesotheliomas.

The NF2 tumor suppressor gene product, merlin, inhibits cell proliferation and cell cycle progression by repressing cyclin D1 expression

High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas.

Management of peritoneal-surface malignancy: the surgeon's role.

Malignant peritoneal mesothelioma: prognostic factors and oncologic outcome analysis

The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma.

A review of peritoneal mesothelioma at the Washington Cancer Institute.

P2888

modpathol.2015.121

P304

14-24

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MODPATHOL.2015.121

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P577

2015-10-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1044159268

http://www.w3.org/2001/XMLSchema#string

P698

26493618

http://www.w3.org/2001/XMLSchema#string